Lysine
Requirements/Sources
Therapeutic Dosages
Therapeutic Uses
What Is the Scientific Evidence for Lysine?
Safety Issues
References
1 Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr . 1997;16:7-21.
2 Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica . 1987;175:183-190.
3 McCune MA, Perry HO, Muller SA, et al. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis . 1984;34:366-373.
4 Simon CA, Van Melle GD, Ramelet AA. Failure of lysine in frequently recurrent herpes simplex infection [letter]. Arch Dermatol . 1985;121:167-168.
5 DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol . 1984;120:48-51.
6 Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol. 1980;60:85-87.
7 Milman N, Scheibel J, Jessen O. Failure of lysine treatment in recurrent herpes simplex labialis [letter]. Lancet. 1978;2:942.
8 Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy . 1981;27:209-213.
9 Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr . 1997;16:7-21.
10 Milman N, Scheibel J, Jessen O. Failure of lysine treatment in recurrent herpes simplex labialis [letter]. Lancet. 1978;2:942.
11 Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica . 1987;175:183-190.
12 McCune MA, Perry HO, Muller SA, et al. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis . 1984;34:366-373.
13 DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol . 1984;120:48-51.
14 Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol. 1980;60:85-87.
15 Kritchevsky D, Weber MM, Klurfeld DM. Gallstone formation in hamsters: Influence of specific amino acids. Nutr Rep Int . 1984;29:117-121.
16 Leszczynski DE, Kummerow FA. Excess dietary lysine induces hypercholesterolemia in chickens. Experientia . 1982;38:266-267.
17 Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy . 1981;27:209-213.
18 Wright EF. Clinical effectiveness of lysine in treating recurrent aphthous ulcers and herpes labialis. Gen Dent. 1994;42(1):40-42.
19 Tomblin FA Jr, Lucas KH. Lysine for management of herpes labialis. Am J Health Syst Pharm. 2001;58(4):298-300,304.
As of 6/8/2011, additional research published on lysine does not warrant any changes to this article.
Revision Information
- Reviewer: EBSCO CAM Review Board
- Review Date: 07/2012 -
- Update Date: 07/25/2012 -
Digg
Del.icio.us
Yahoo
Google
Newsvine